Aaron King is a molecular bioscientist and research leader specializing in biomarker discovery, biological aging, and healthspan optimization. 

As Founder & Scientist of Aeon Biomarkers, Aaron is at the forefront of developing next-generation biomarker analysis platforms that translate complex metabolic and inflammatory data into clear, actionable insights for proactive health management.

Aaron earned his Master’s degree in Molecular Bioscience and Bioengineering from the University of Hawai‘i at Mānoa and his Bachelor’s degree in Biology from the University of California, Irvine. His scientific expertise centers on biological age modeling, mitochondrial health metrics, and the longitudinal tracking of biomarker patterns that predict aging trajectory and resilience.

Prior to co-founding Aeon Biomarkers, Aaron served in research leadership roles, driving initiatives focused on the early detection of metabolic dysfunction and chronic disease risk.